Offer - Urjas Oil for just ₹ 1 X
Atovastrin CV is an allopathic medicine The correct dosage of Atovastrin CV depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Atovastrin CV is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Atovastrin CV safe for pregnant women?
Pregnant women may experience moderate side effects from Atovastrin CV. It is best to stop taking Atovastrin CV immediately and inform your doctor if you notice any discomfort.
Is the use of Atovastrin CV safe during breastfeeding?
Side effects of Atovastrin CV on breastfeeding women are very mild.
What is the effect of Atovastrin CV on the Kidneys?
Atovastrin CV rarely affects the kidneys.
What is the effect of Atovastrin CV on the Liver?
Atovastrin CV can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Atovastrin CV on the Heart?
Very few cases of side effects of Atovastrin CV on the heart have been reported.
Atovastrin CV should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Atovastrin CV unless your doctor advises you to do so -
Is this Atovastrin CV habit forming or addictive?
Atovastrin CV does not cause addiction.
Interaction between Food and Atovastrin CV
Eating certain foods may increase the time it takes Atovastrin CV to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Atovastrin CV
Information about the interaction of Atovastrin CV and alcohol is not currently available because this topic has not been researched yet.
Yes, Atovastrin CV has been reported to cause diarrhea but this occurs in a few cases only. It is the most common side effect of this medicine. Drink plenty of fluids while you are taking this medicine. If you are experiencing severe diarrhea after taking this drug, consult your doctor immediately without any further delay.
Yes, Atovastrin CV is safe to use, if taken in a prescribed amount for a specified time as advised by the doctor. However, few side effects are observed at regular doses such as confusion, diarrhea, joint pain, and muscle pain. Do not hesitate to inform your doctor if you are facing any of the above.
Yes, Atovastrin CV can be taken in the morning. It can be taken anytime once in a day with food or without food or as advised by your doctor.
Yes, Atovastrin CV can be taken with ibuprofen. No harmful drug interaction has been reported between them. However, if you feel any discomfort after taking ibuprofen do not hesitate to inform your doctor.
Atovastrin CV is a brand name of atorvastatin which belongs to the class of drugs known as statins (dyslipidemic agents). It is a prescription drug that is used for the treatment of mixed dyslipidemia (high levels of lipids in the blood), hypercholesterolemia (high cholesterol levels), and hypertriglyceridemia.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lipitor® (Atorvastatin Calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 637-638
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Plavix (clopidogrel bisulfate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 630-631
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 335-336